Technische Universität Darmstadt, Germany
Conference Chair
Dr. Wolfgang Ensinger studied chemistry and physics at the Universities in Karlsruhe and Heidelberg in Germany. He received his PhD in 1988 from Heidelberg University. Thereafter, he was a guest researcher at Osaka National Research Institute in Japan, lecturer at Institute of Solid State Physics at University Augsburg and professor of Analytical and Nuclear Chemistry at University of Marburg. Since 2004, he is a full professor of Material Analysis at Technical University of Darmstadt in Germany. His research topics include formation of thin films and nanostructures, including nanochannels, nanowires and nanotubes. He has authored/co-authored more than 200 peer-reviewed scientific publications.
Comenius University, Slovakia
Conference Chair
Dr. Josef Jampilek completed his Ph.D. degree in Medicinal Chemistry at the Faculty of Pharmacy of the Charles University (Czech Republic) in 2004. In 2004-2011, he worked in expert and managerial posts in the R&D Division of the pharmaceutical company Zentiva (Czech Republic). Prof. Jampilek deepened his professional knowledge at the Medicinal Chemistry Institute of the Heidelberg University (Germany) and at multiple specialized courses. In 2017, he was designated as a Full Professor of Medicinal Chemistry. At present he works at the Regional Centre of Advanced Technologies and Materials, Palacky University in Olomouc (Czech Republic) and the Faculty of Natural Sciences, Comenius University in Bratislava (Slovakia). In addition, he is a visiting professor at the University of Silesia in Katowice (Poland) and Hong Kong Baptist University (Hong Kong SAR, China) and an invited professor/expert at various higher educational institutions. He is an author/co-author of more than 30 patents/patent applications, more than 200 peer-reviewed scientific publications, 7 university textbooks, more than 30 chapters in monographs, and many invited lectures at international conferences and workshops. He also received several awards for his scientific results, e.g., from Aventis, Elsevier, Willey, Sanofi and FDA. The research interests of Prof. Jampilek include design, synthesis, and structure-activity relationships of heterocyclic compounds as anti-invasive and anti-inflammatory agents as well as nanosystems. He is also interested in ADME, drug bioavailability and solid-state pharmaceutical analysis.
The University of Lancashire, UK
Conference Chair
Dr. Antonios Kelarakis has established a long track record in ground-breaking research and product development and his publications cover a broad area of topics related to nanomaterials, nanocomposites, nanosensors, colloids, polymers, smart coatings, aerogels, biomaterials, energy materials and forensic nanotools. Antonios’ research is interdisciplinary in nature (it combines elements from material science, nanotechnology, chemistry, biology, pharmacy and medicine) and emphasizes on the development of a new generation of energy-efficient materials and the establishment of green chemical approaches for a sustainable future.
University of Alberta. Canada
Conference Chair
Dr. D.Y. Li is a Professor at Dept. of Chemical & Materials Eng., University of Alberta. His interests of research include surfaces and interfaces, wear and corrosion-wear synergy, material design, and computational materials science. Dr. Li obtained a B.Sc. in Theoretical and Applied Mechanics from University of Science and Technology China, a M.Sc. in Condensed Matter Physics from Sun Yat-sen University, a PhD in Materials Physics from University of Science and Technology Beijing, and a PhD in Metallurgical Engineering from McGill University. Before joining U. of Alberta in 1998, he worked as a postdoctoral fellow at the Pennsylvania State University (1995–97). He is an Adjunct Professor of Biomedical Engineering at U. of Alberta, and also holds adjunct professorship at several foreign universities. Dr. Li is the recipient of MetSoc Airey Award (Lifetime Achievement, 2025), Physics Award (MetSoc-CIM 2024), Research Excellence Award (CIM, 2024), 2020 Distinguished Materials Scientist Award, and other honors & awards. He is on the editorial board for eighteen technical journals. Dr. Li has in excess of 530 scientific publications, including 480+ refereed journal publications. He is an invited contributor for authoritative handbooks/encyclopaedia (Elsevier, Springer, and ASM International) in wear and tribology.
Newcastle University, UK
Conference Chair
Moein Moghimi is a Professor of Pharmaceutics and Nanomedicine at the School of Pharmacy, Translational and Clinical Research Institute, and Centre for Biomedical Engineering, Newcastle University (UK), and Adjoint Professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus (USA). His earlier senior academic positions included Chair of Nanomedicine at Durham University (UK), Professor of Nanomedicine and Director of Centre for Pharmaceutical Nanotechnology and Nanotoxicology at Copenhagen University (Denmark), Visiting Professor at the University of Padova (Italy) and Affiliate Professor at Houston Methodist Research Institute (Texas, USA). He is co-founder of spin-offs in USA and UK, and further serves as the Editor-in-Chief of Drug Delivery (Taylor & Francis) and Associate Editor of Molecular Therapy (Cell Press).
Prof. Moghimi is an internationally acclaimed leader in drug delivery, nanomedicine and immunosafety research, and his pioneering contributions continue to impact and influence the development of next-generation target-specific and target-sensitive nanomedicines and translational biomedical innovation. He has extensively published, cited, and spoken in the field, and widely reported by the press. For the sixth consecutive year, the Elsevier’s “Updated Science-Wide Author Databases of Standardized Citation Indicators - Version 8, 2025” ranks Prof. Moghimi among the world’s leading 0.1% of all scientists within 22 scientific fields, and places him in the top 50 scientists in the world under Pharmacology & Pharmacy Science-Metrix subfield on a career-long basis. In 1985, he graduated with Honors in Biochemistry from the University of Manchester (UK), and completed a PhD in Biochemistry at Charing Cross and Westminster Medical School (Imperial College, London), followed by post-doctoral training at the School of Pharmacy, Nottingham University (UK).
University of Rome Tor Vergata, Italy
Conference Chair
Maria Luisa Di Vona is a Professor of Chemistry in the Department of Industrial Engineering at the University of Rome Tor Vergata. She is the director of the International Laboratory Ionomer Materials for Energy (LIME). Research Interests: Materials for energy; design and characterization of conductive membranes and ionomers for electrochemical devices (fuel cells, electrolysers, redox-flow batteries); fabrication and application of nanostructured catalytic electrodes (doped carbon quantum dots, LDH, organic–inorganic hybrid materials). Professor Di Vona has organized numerous international symposia and has served on organizational and scientific committees for several scientific societies. Since 2016 she has been the coordinator of the International Master’s Degree Programme Chemical Nano-Engineering (LM-71), funded by the EU in 2016 and in 2020 as an Erasmus Mundus Joint Master Degree. Professor Di Vona has held various academic and teaching responsibilities, including participation in institutional committees, selection and evaluation boards, and doctoral thesis committees in Italy and abroad. She collaborates with multiple companies through formal agreements. She is the author of more than 200 publications, including 170 papers in international journals, 7 book chapters, 2 books, and 4 patents. She has delivered over 200 presentations at national and international conferences, including numerous keynote and invited lectures. Most recently, she received the Distinguished Thermec Award for “outstanding research in the area of hybrid and nano-materials for energy and leadership in chemical nano-engineering education in Europe.”